Rice Hall James & Associates’s CryoPort CYRX Stock Holding History
Bought
Maintained
Sold
Other funds holding CYRX
FAM
BCM
GIP
Rice Hall James & Associates's CYRX Position: Q1 2022 in Review
Rice Hall James & Associates sold out of CryoPort (CYRX) in Q1 2022, closing a stake of 46,749 shares — an estimated $2.77M sold.
Rice Hall James & Associates first reported a position in CYRX in Q1 2018 and held it in 16 quarters. The position peaked at $2.77M in Q4 2021. 200 funds tracked by Wall St. Rank hold CYRX as of Q1 2022.
- Rice Hall James & Associates reported no remaining CryoPort position as of Q1 2022 after selling out during the quarter.
- Rice Hall James & Associates sold 46,749 CryoPort shares in Q1 2022, an estimated $2.77M.
- Rice Hall James & Associates first reported a position in CryoPort in Q1 2018 and held it in 16 quarters.
- Rice Hall James & Associates's CryoPort position peaked at $2.77M in Q4 2021.
- 200 funds tracked by Wall St. Rank held CryoPort as of Q1 2022.
Based on Rice Hall James & Associates's 13F filing for Q1 2022, filed 5 May 2022.